nortriptyline has been researched along with Genetic Predisposition in 5 studies
Nortriptyline: A metabolite of AMITRIPTYLINE that is also used as an antidepressive agent. Nortriptyline is used in major depression, dysthymia, and atypical depressions.
nortriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(methylamino)propylidene group at position 5. It is an active metabolite of amitriptyline.
| Excerpt | Relevance | Reference |
|---|---|---|
| " A total of 796 adult patients with major depressive disorder who were treated with a flexible dosage of escitalopram or nortriptyline in Genome-based Therapeutic Drugs for Depression (GENDEP) were included in the sample and provided data on suicidal ideation." | 2.74 | Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project. ( Aitchison, KJ; Bonvicini, C; Craig, I; Farmer, AE; Gray, J; Gupta, B; Hauser, J; Henigsberg, N; Huezo-Diaz, P; Jorgensen, L; Kalember, P; Kapelski, P; Lewis, CM; Maier, W; Marusic, A; McGuffin, P; Mors, O; Perroud, N; Petrovic, A; Placentino, A; Rietschel, M; Schulze, TG; Smith, R; Souery, D; Uher, R; Zobel, A, 2009) |
| "Risk factors such as borderline personality disorder and childhood abuse experiences were systematically assessed, and patients were genotyped for polymorphisms of GNbeta3." | 2.72 | Genetic, developmental and personality correlates of self-mutilation in depressed patients. ( Joyce, PR; Kennedy, MA; Luty, SE; McKenzie, JM; Miller, AL; Mulder, RT; Sullivan, PF, 2006) |
| "Management of MdDS as vestibular migraine can improve patients' symptoms and increase the QOL." | 1.46 | Management of mal de debarquement syndrome as vestibular migraines. ( Bhatt, J; Djalilian, HR; Ghavami, Y; Haidar, YM; Lin, HW; Moshtaghi, O; Ziai, KN, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fjær, R | 1 |
| Marciniak, K | 1 |
| Sundnes, O | 1 |
| Hjorthaug, H | 1 |
| Sheng, Y | 1 |
| Hammarström, C | 1 |
| Sitek, JC | 1 |
| Vigeland, MD | 1 |
| Backe, PH | 1 |
| Øye, AM | 1 |
| Fosse, JH | 1 |
| Stav-Noraas, TE | 1 |
| Uchiyama, Y | 1 |
| Matsumoto, N | 1 |
| Comi, A | 1 |
| Pevsner, J | 1 |
| Haraldsen, G | 1 |
| Selmer, KK | 1 |
| Zwicker, A | 1 |
| Fabbri, C | 1 |
| Rietschel, M | 2 |
| Hauser, J | 2 |
| Mors, O | 2 |
| Maier, W | 2 |
| Zobel, A | 2 |
| Farmer, A | 1 |
| Aitchison, KJ | 2 |
| McGuffin, P | 2 |
| Lewis, CM | 2 |
| Uher, R | 2 |
| Ghavami, Y | 1 |
| Haidar, YM | 1 |
| Ziai, KN | 1 |
| Moshtaghi, O | 1 |
| Bhatt, J | 1 |
| Lin, HW | 1 |
| Djalilian, HR | 1 |
| Perroud, N | 1 |
| Smith, R | 1 |
| Huezo-Diaz, P | 1 |
| Marusic, A | 1 |
| Placentino, A | 1 |
| Henigsberg, N | 1 |
| Souery, D | 1 |
| Kapelski, P | 1 |
| Bonvicini, C | 1 |
| Jorgensen, L | 1 |
| Petrovic, A | 1 |
| Kalember, P | 1 |
| Schulze, TG | 1 |
| Gupta, B | 1 |
| Gray, J | 1 |
| Farmer, AE | 1 |
| Craig, I | 1 |
| Joyce, PR | 1 |
| McKenzie, JM | 1 |
| Mulder, RT | 1 |
| Luty, SE | 1 |
| Sullivan, PF | 1 |
| Miller, AL | 1 |
| Kennedy, MA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Genetics of Self-injurious Behaviour[NCT05563324] | 234 participants (Actual) | Observational | 2014-05-09 | Completed | |||
| Influences on and Prevention of Self-harm Behaviour Among the Most At-risk Adolescents[NCT05765864] | 400 participants (Anticipated) | Observational | 2023-03-23 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for nortriptyline and Genetic Predisposition
| Article | Year |
|---|---|
Genetic disposition to inflammation and response to antidepressants in major depressive disorder.
Topics: Adrenergic Uptake Inhibitors; Adult; C-Reactive Protein; Citalopram; Depressive Disorder, Major; Fem | 2018 |
Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project.
Topics: Adult; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Citalopram; Depressive Disorder, Ma | 2009 |
Genetic, developmental and personality correlates of self-mutilation in depressed patients.
Topics: Adolescent; Adult; Alleles; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricycl | 2006 |
Genetic, developmental and personality correlates of self-mutilation in depressed patients.
Topics: Adolescent; Adult; Alleles; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricycl | 2006 |
Genetic, developmental and personality correlates of self-mutilation in depressed patients.
Topics: Adolescent; Adult; Alleles; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricycl | 2006 |
Genetic, developmental and personality correlates of self-mutilation in depressed patients.
Topics: Adolescent; Adult; Alleles; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricycl | 2006 |
2 other studies available for nortriptyline and Genetic Predisposition
| Article | Year |
|---|---|
A novel somatic mutation in GNB2 provides new insights to the pathogenesis of Sturge-Weber syndrome.
Topics: Adolescent; Adult; Child; DNA Mutational Analysis; Exome Sequencing; Gene Frequency; Genetic Associa | 2021 |
Management of mal de debarquement syndrome as vestibular migraines.
Topics: Adult; Aged; Drug Therapy, Combination; Female; Fructose; Genetic Predisposition to Disease; Humans; | 2017 |